Published in J Thorac Cardiovasc Surg on March 01, 2007
Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension. J Heart Lung Transplant (2010) 1.51
Pulmonary hypertension with left-sided heart disease. Nat Rev Cardiol (2010) 1.19
Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation (2012) 1.11
Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. Curr Opin Cardiol (2011) 1.04
Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device. J Artif Organs (2012) 0.84
Initial Experience with Sildenafil, Bosentan, and Nitric Oxide for Pediatric Cardiomyopathy Patients with Elevated Pulmonary Vascular Resistance before and after Orthotopic Heart Transplantation. J Transplant (2010) 0.81
Assessment of right ventricular function in left ventricular assist device candidates. Circ Cardiovasc Imaging (2014) 0.81
Acute pulmonary vasoreactivity test with sildenafil or nitric monoxide before left ventricular assist device implantation. J Artif Organs (2013) 0.80
Right ventricular dysfunction during intensive pharmacologic unloading persists after mechanical unloading. J Card Fail (2009) 0.79
Impact of pulmonary vascular resistances in heart transplantation for congenital heart disease. Curr Cardiol Rev (2011) 0.78
A heart transplant candidate with severe pulmonary hypertension and extremely high pulmonary vascular resistance. J Artif Organs (2013) 0.77
High pulmonary vascular resistance in addition to low right ventricular stroke work index effectively predicts biventricular assist device requirement. J Artif Organs (2015) 0.76
Mechanical circulatory support devices as destination therapy-current evidence. Ann Cardiothorac Surg (2014) 0.76
Pulmonary Hypertension in the Era of Mechanical Circulatory Support. ASAIO J (2016) 0.75
New role of ventricular assist devices as bridge to transplantation: European perspective. Curr Opin Organ Transplant (2017) 0.75
Hospital and intensive care unit management of decompensated pulmonary hypertension and right ventricular failure. Heart Fail Rev (2016) 0.75
Management of pulmonary hypertension from left heart disease in candidates for orthotopic heart transplantation. J Thorac Dis (2017) 0.75
Second internal thoracic artery versus radial artery in coronary artery bypass grafting: a long-term, propensity score-matched follow-up study. Circulation (2011) 3.09
Randomized comparison of strategies for type B aortic dissection: the INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD) trial. Circulation (2009) 2.78
Retrograde ascending aortic dissection during or after thoracic aortic stent graft placement: insight from the European registry on endovascular aortic repair complications. Circulation (2009) 2.74
Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial. Circ Cardiovasc Interv (2013) 2.69
Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation (2007) 2.58
Release of neuron-specific enolase and S100 after implantation of cardioverters/defibrillators. Crit Care Med (2003) 2.57
Interdisciplinary expert consensus document on management of type B aortic dissection. J Am Coll Cardiol (2013) 2.24
Perioperative use of levosimendan: best practice in operative settings. J Cardiothorac Vasc Anesth (2012) 2.15
The vacuum-assisted closure system for the treatment of deep sternal wound infections after cardiac surgery. Ann Thorac Surg (2002) 1.97
Novel insights into the mechanisms and treatment of intramural hematoma affecting the entire thoracic aorta. Ann Thorac Surg (2008) 1.76
Midterm follow-up of tricuspid valve reconstruction due to active infective endocarditis. Ann Thorac Surg (2007) 1.74
Endovascular aortic arch repair after aortic arch de-branching. Ann Thorac Surg (2009) 1.72
The La-related protein LARP7 is a component of the 7SK ribonucleoprotein and affects transcription of cellular and viral polymerase II genes. EMBO Rep (2008) 1.68
Platelet dysfunction in outpatients with left ventricular assist devices. Ann Thorac Surg (2009) 1.68
One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J (2010) 1.63
Heat shock proteins 27, 60, 70, 90alpha, and 20S proteasome in on-pump versus off-pump coronary artery bypass graft patients. Ann Thorac Surg (2008) 1.63
Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation (2005) 1.62
Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling. J Cardiovasc Pharmacol (2010) 1.61
Evidence, lack of evidence, controversy, and debate in the provision and performance of the surgery of acute type A aortic dissection. J Am Coll Cardiol (2011) 1.59
Endovascular treatment of patients with types A and B thoracic aortic dissection using Relay thoracic stent-grafts: results from the RESTORE Patient Registry. J Endovasc Ther (2011) 1.58
Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation. Cardiovasc Res (2008) 1.54
Gender differences in clinical presentation and surgical outcome of aortic stenosis. Heart (2010) 1.50
Neurocognitive deficit following mitral valve surgery. Eur J Cardiothorac Surg (2003) 1.49
Cerebrospinal fluid drainage as a useful treatment option to relieve paraplegia after stent-graft implantation for acute aortic dissection type B. J Thorac Cardiovasc Surg (2002) 1.49
The location of the primary entry tear in acute type B aortic dissection affects early outcome. Eur J Cardiothorac Surg (2012) 1.48
Outcome of combined stenotic and regurgitant aortic valve disease. J Am Coll Cardiol (2013) 1.47
The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation. Thromb Haemost (2005) 1.46
New insights regarding the incidence, presentation and treatment options of aorto-oesophageal fistulation after thoracic endovascular aortic repair: the European Registry of Endovascular Aortic Repair Complications. Eur J Cardiothorac Surg (2013) 1.45
Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg (2004) 1.44
Endovascular stent-graft placement of aneurysms involving the descending aorta originating from chronic type B dissections. Ann Thorac Surg (2007) 1.43
Midterm results after endovascular treatment of acute, complicated type B aortic dissection. Ann Thorac Surg (2010) 1.43
Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy. Cardiovasc Res (2008) 1.42
Mechanical aortic valve prostheses in the small aortic root: Top Hat versus standard CarboMedics aortic valve. Ann Thorac Surg (2008) 1.42
Matrix metalloproteases and their tissue inhibitor in cardiac transplantation. Eur J Cardiothorac Surg (2007) 1.41
Should aortic arch replacement be performed during initial surgery for aortic root aneurysm in patients with Marfan syndrome? Eur J Cardiothorac Surg (2013) 1.40
Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med (2004) 1.40
Assessment of gene transcription demonstrates connection with the clinical course of idiopathic interstitial pneumonia. Respiration (2008) 1.40
Quinaprilat during cardioplegic arrest in the rabbit to prevent ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2002) 1.39
Triangular plication of the anterior mitral leaflet: a new operative technique. Ann Thorac Surg (2004) 1.39
Cerebrospinal fluid drainage duration after thoracoabdominal aortic aneurysm repair. Anesthesiology (2003) 1.38
European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system. Eur J Cardiothorac Surg (2009) 1.32
Surgical ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ultrasound: results of a multicenter trial. J Thorac Cardiovasc Surg (2005) 1.29
Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance. Biochem Biophys Res Commun (2003) 1.28
Natural history of very severe aortic stenosis. Circulation (2009) 1.27
Mitochondrial ROS production under cellular stress: comparison of different detection methods. Anal Bioanal Chem (2011) 1.24
Mechanisms of failure and outcome of secondary surgical interventions after thoracic endovascular aortic repair (TEVAR). Ann Thorac Surg (2011) 1.24
Acute type A aortic dissection and pregnancy: a population-based study. Eur J Cardiothorac Surg (2011) 1.24
Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death. Biochim Biophys Acta (2011) 1.22
Systematic review of clinical outcomes in hybrid procedures for aortic arch dissections and other arch diseases. J Thorac Cardiovasc Surg (2012) 1.21
Isolation and detection of Campylobacter concisus from saliva of healthy individuals and patients with inflammatory bowel disease. J Clin Microbiol (2010) 1.20
Elevated serum levels of epithelial cell apoptosis-specific cytokeratin 18 neoepitope m30 in critically ill patients. Shock (2004) 1.20
Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase. J Cardiovasc Pharmacol (2003) 1.19
Suction events during left ventricular support and ventricular arrhythmias. J Heart Lung Transplant (2007) 1.14
Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue. Circ Res (2011) 1.12
Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care (2010) 1.10
Acute aortic dissection determines the fate of initially untreated aortic segments in Marfan syndrome. Circulation (2013) 1.09
Ca2+/Calmodulin-dependent protein kinase II δ mediates myocardial ischemia/reperfusion injury through nuclear factor-κB. Circ Res (2013) 1.08
Combined repair of an aortic arch aneurysm by sequential transposition of the supra-aortic branches and endovascular stent-graft placement. J Thorac Cardiovasc Surg (2003) 1.08
Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation. J Heart Lung Transplant (2009) 1.07
Supra-aortic transposition for combined vascular and endovascular repair of aortic arch pathology. Ann Thorac Surg (2008) 1.07
Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg (2007) 1.06
Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. Tissue Eng (2005) 1.05
Muscle relaxation does not alter hypnotic level during propofol anesthesia. Anesth Analg (2002) 1.05
Adenovirus-mediated overexpression of inhibitor kappa B-alpha attenuates postinfarct remodeling in the rat heart. Eur J Cardiothorac Surg (2004) 1.05
Fleece bound sealing prevents pleural adhesions. Interact Cardiovasc Thorac Surg (2006) 1.04
Lung wedge resection improves outcome in stage I primary spontaneous pneumothorax. Ann Thorac Surg (2004) 1.04
Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age. J Thorac Cardiovasc Surg (2012) 1.04
Thoracic Endovascular Aortic Repair (TEVAR) for the treatment of aortic diseases: a position statement from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg (2012) 1.04
Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J Heart Valve Dis (2006) 1.02
Should intentional endovascular stent-graft coverage of the left subclavian artery be preceded by prophylactic revascularisation? Eur J Cardiothorac Surg (2011) 1.02
The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells. Circulation (2012) 1.02
Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis. J Thorac Cardiovasc Surg (2013) 1.01
Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg (2009) 0.99
Stent-graft placement in atherosclerotic descending thoracic aortic aneurysms: midterm results. J Endovasc Ther (2004) 0.99
Treatment of symptomatic coral reef aorta by endovascular stent-graft placement. Ann Thorac Surg (2008) 0.99
Mechanical circulatory support as a bridge to heart transplantation: what remains? Long-term emotional sequelae in patients and spouses. J Heart Lung Transplant (2007) 0.98
Strategies for subacute/chronic type B aortic dissection: the Investigation Of Stent Grafts in Patients with type B Aortic Dissection (INSTEAD) trial 1-year outcome. J Thorac Cardiovasc Surg (2010) 0.98
Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Ann Thorac Surg (2004) 0.97